Deploying the Enhanced Visual Assessment (EVA) System at initial cervical cancer screenings leads to a higher detection rate of suspected precancerous and cancerous lesions for women in both urban and rural areas, than a Pap smear alone, according to a 2017 study conducted by MobileODT and Apollo Hospitals in India.
India is home to one third of all deaths from cervical cancer globally, where 453 million women are at risk of developing the preventable disease. Sadly, women are often diagnosed with cervical cancer during their childbearing and child-raising years. Despite this, only 3.1% of women in India are screened.
Through the World Bank/IFC-funded study, Apollo Hospitals and MobileODT partnered to assess the EVA System as a technological tool for high-quality and more cost-effective cervical cancer screenings for women across the country.
The study addressed the many challenges both public and private healthcare providers face by evaluating the feasibility of the EVA System’s software - including overcoming the resource intensive requirements for traditional screening methods including a Pap smear that require supplies, laboratories, and pathologists.
Led by Dr. Malika Samuel, the far reaching effort resulted in 567 women being enrolled in the study. The study team was comprised of 29 dedicated, talented health care providers at seven diverse clinical locations — from super-specialty hospitals in urban areas, to remote rural outreach centers a part of Apollo’s Total Health Program.
During the study, women were screened through colposcopy with the EVA System, as well as with Pap smears for cervical cancer and other abnormalities at the first screening. Findings showed a higher rate of identification of suspected precancerous lesions by including a visual assessment with the EVA System than a Pap smear alone. A review of cases by expert gynecologists confirmed these conclusions using software as part of the EVA System solution.
Whilst full results of the study will be published in 2018, additional findings revealed gynecologists conducting screenings scored either 4/5 out of 5 on all measures of feasibility, usability, and patient satisfaction with the EVA System. Gynecologists shared that the EVA System proved to be a quick and easy way to evaluate the cervix, and all investigators felt it can be extended to peripheral centers with training where Pap smear collection and interpretation is not easily available.
Anecdotally, when women were shown images of their cervix, and provided with results at the time of screening, providers commented that patients expressed they were more likely to seek treatment and had a greater awareness of cervical cancer prevention.
Now that the pilot is over, we are excited to be working with Apollo Hospitals to expand the use of the EVA System across its large network.
Together, we are working towards a brighter, more healthy future for all women in India, as we know that when we invest in women's health, our efforts can also help to reduce infant mortality, malnutrition, and poverty, as well as an increase in individual and nation wide economic growth.
To use the EVA System in India, contact:
Overall, El Salvador has the lowest reported cervical cancer screening coverage compared to other countries in the region, particularly amongst high-risk and vulnerable populations in hard-to-reach areas of the country, low-socioeconomic groups and indigenous women. As a result, according to HPV Center, 2 million women in El Salvador are at risk of developing cervical cancer, over 800 women are diagnosed with the disease each year, and almost 400 die annually.
Basic Health International (BHI) and El Salvador’s Ministry of Health have been tirelessly working side-by-side to change this reality by piloting different methods to extend cervical cancer screening to the women most in need.
In 2015, BHI approached MobileODT to see if deployment of the EVA System could help build capacity and provide real-time support to health providers in remote areas of the country. They were particularly interested in:
Our partners at Tristel, have also joined the effort by deploying their easy-to-apply disinfectant solution that enables health providers to quickly clean exam equipment between patients rather than sending equipment out for cleaning every evening off-site, saving both time and money.
Together, we are working to end preventable deaths from cervical cancer in a generation, and proud to work with Tristel, BHI and the Ministry of Health in El Salvador to make this dream a more realistic reality.
To deploy the EVA System in your global health program contact: email@example.com